Annalisa Adamo

Verona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

c-FLIP as a master regulator of immune homeostasis and disease mechanisms.

c-FLIP as a master regulator of immune homeostasis and disease mechanisms.

Journal: Cell death & disease
Published: January 06, 2026

Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy.

Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy.

Journal: Cell
Published: April 14, 2025

Local ablation disrupts immune evasion in pancreatic cancer.

Local ablation disrupts immune evasion in pancreatic cancer.

Journal: Cancer letters
Published: August 09, 2024

Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation.

Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 23, 2024

Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1.

Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1.

Journal: ACS pharmacology & translational science
Published: May 03, 2024

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.

Journal: bioRxiv : the preprint server for biology
Published: December 18, 2023

GateMeClass: Gate Mining and Classification of cytometry data.

GateMeClass: Gate Mining and Classification of cytometry data.

Journal: Bioinformatics (Oxford, England)
Published: November 15, 2023

B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.

B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.

Journal: Scientific reports
Published: October 31, 2023

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.

Journal: Oncoimmunology
Published: September 18, 2023

Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients.

Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients.

Journal: Cancers
Published: September 13, 2023

Neutralization of NET-associated human ARG1 enhances cancer immunotherapy.

Neutralization of NET-associated human ARG1 enhances cancer immunotherapy.

Journal: Science translational medicine
Published: March 15, 2023

Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.

Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.

Journal: Gut
Published: March 02, 2023
Showing 1-12 of 28

Last Updated: 09/26/2026